Back to Emergency Medicine
Emergency Medicinev1998Evidence-Based

Centor Score (Modified/McIsaac) for Strep Pharyngitis

Estimates likelihood that pharyngitis is streptococcal and suggests management course. Modified version includes age adjustment and provides evidence-based approach to antibiotic prescribing and testing decisions.

Clinical Input Parameters

years
Range: 3 — 120 years
Clinical Assessment
Awaiting Parameters
centor assessment
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Centor Score (Modified/McIsaac) for Strep Pharyngitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Modified Centor Score = Tonsillar exudate (1) + Tender cervical nodes (1) + History of fever (1) + Absence of cough (1) + Age adjustment: 3-14 years (+1), 15-44 years (0), ≥45 years (-1). Total range: -1 to +5 points.

Clinical Pearls & Practice Notes

  • Modified by McIsaac et al. 1998 to include age adjustment
  • Age 3-14 years: +1 point (higher risk of streptococcal infection)
  • Age 15-44 years: 0 points (baseline risk)
  • Age ≥45 years: -1 point (lower risk of streptococcal infection)
  • Score ≤1: No testing or antibiotics needed (1-10% GAS probability)
  • Score 2-3: RADT and/or culture recommended (11-35% GAS probability)
  • Score ≥4: Consider empiric treatment or testing (51-53% GAS probability)
  • Reduces unnecessary antibiotic prescriptions by 48%
  • Current IDSA guidelines recommend testing before antibiotic treatment
  • Should not be used as sole decision-making tool - clinical judgment important
  • Valid for both children and adults presenting with sore throat
  • Does not apply to patients with recent streptococcal exposure
  • Consider alternative diagnoses if recurrent episodes
  • Validated across multiple healthcare settings

Evidence & Literature Citations

  1. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239-46. doi: 10.1177/0272989X8100100304.
  2. McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998 Jan 13;158(1):75-83.
  3. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004 Apr 7;291(13):1587-95. doi: 10.1001/jama.291.13.1587.
  4. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102. doi: 10.1093/cid/cis629.

Score Interpretation Ranges

Low Risk-1 – 1 pts

Low probability of streptococcal infection

Moderate Risk2 – 3 pts

Moderate probability of streptococcal infection

High Risk4 – 5 pts

High probability of streptococcal infection

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.